Critical Laboratory Results: How to Make Sure They Reach the Clinician and Close the Reporting Loop

Why is an alert in the system not enough?

A critical result needs a pathway that delivers it to a responsible clinician, proves that clinician received it and links it to documented clinical follow-up. An alert appearing in the electronic system does not, on its own, prove that the right person read it or acted on it.

The CDC’s Core Elements of Hospital Diagnostic Excellence calls on hospitals to clarify responsibility for following up abnormal findings, to make sure diagnostic results reliably reach the clinician responsible for follow-up through closed-loop communication or similar methods, and to adopt policies and standard workflows for communicating critical results, with adherence assessed over time. ^[1]

What makes a result critical?

Falling outside the reference range does not make every result an emergency. The Joint Commission leaves each organisation to decide for itself when a test result is critical and how it will be reported. ^[3] The list is best agreed between the laboratory and clinical leaders, according to the services offered and the patients treated.

The policy should also explain how to handle repeat results, values that are expected for particular patients because of a chronic condition, and who reviews the list when tests or methods change. If the organisation allows patient- or diagnosis-specific parameters, they must be objectively defined and known to everyone involved in reporting. ^[4] Laboratory thresholds and reporting timeframes are institutional clinical decisions for the organisation’s own specialists to approve.

How do you map a pathway where responsibility is never lost?

When reviewing the policy, separate three things: technical verification of the result, its communication, and clinical follow-up. The laboratory technician’s role may end once the approved notification is completed and recorded, while responsibility for the treatment decision stays with the receiving team. That is why the whole pathway is reviewed, not the laboratory’s performance in isolation.

The SAFER guide on test results reporting and follow-up recommends that the electronic record tracks each test order through its stages up to result release and acknowledgement, and that known weak points such as shift changes and care transitions are identified. ^[2] In practice, this means a status log that distinguishes “result available”, “notification started”, “receipt confirmed by recipient” and “follow-up documented”.

The guide also recommends that critical values are flagged in a way that is visually distinct from ordinary abnormal results, so they are not lost in a long list of alerts. ^[2]

The suggested log records patient identifiers in line with local policy, the test name and release time, the identity and role of the reporter and recipient, the communication channel, the time receipt was confirmed and any escalation attempts. The clinical note sits in its proper place in the patient record, with a link so that no one has to hunt for it across separate systems.

What happens if the doctor does not answer?

The SAFER guide recommends escalation processes for urgent results that go unacknowledged within a defined time, using an alternative communication channel, and policies that cover shift handovers, rotations off service and staff leaving. It also recommends an up-to-date contact list tied to cover rotas, and the ability to assign a covering clinician to receive notifications during planned and unplanned absences. ^[2]

In practice, the organisation names the responsible deputy, how the reporter reaches them and when to move to the next level according to the agreed urgency. An out-of-date list of phone numbers does not achieve this. Test the pathway with announced simulations and review real communication failures, without using real patient data in training exercises.

Test electronic alerts from the user’s point of view: which inbox does the alert land in? Does it change destination after a shift change? What is the fallback if the system goes down? The guide also lists tests still pending at discharge among the situations vulnerable to follow-up failure, and expects their results to reach a clinician responsible for follow-up care. ^[2]

Hypothetical example: a report closed without anyone receiving it

In a hypothetical hospital, the laboratory sent an urgent result to the doctor named on the test request, who had already finished their shift. The system showed the message as sent, so the report was closed, yet no responsible clinician had accepted the follow-up. The review found that the fault lay in how “closed” was defined and in out-of-date contact details, not in how quickly the result was issued.

The improvement team proposed separating “sent” from “receipt confirmed”, linking the deputy to the duty rota and showing reports awaiting acceptance on a follow-up list. The change was then piloted in one department and exceptions were reviewed before roll-out. This is a teaching case, not drawn from a real facility, and claims no improvement figures.

What should management measure?

The SAFER guide recommends monitoring whether clinicians acknowledge results and how long acknowledgement takes, and keeping error logs and queues so that results that cannot be delivered automatically are handled manually. ^[2] The CDC framework calls for tracking cases where a result goes to the wrong clinician, to a clinician who has left the service, or is not received at all. ^[1]

Choose measures that show where the process breaks down:

• Time from result release to notification of the approved recipient.
• Proportion of reports with documented confirmation of receipt.
• Reports that needed escalation, and why.
• Cases left without a clear follow-up owner.

Define the start point, end point and denominator for each measure. A notification-time measure is meaningless if one department starts the clock at sample collection and another at result release. Review delayed cases individually alongside the summary figures, because a good average can hide a high-risk case.

Present the results to the quality or patient safety committee regularly, with a specific improvement plan for any department where stalled cases recur, then follow up the effect of the change in the next cycle rather than simply recording it.

Questions for reviewing your current policy

Before changing the system or writing a new policy, bring together the laboratory, nursing, medical staff, IT and the quality team, and answer these questions together:

1. Who approves the critical results list, and when was it last reviewed?
2. How does the policy define a “closed” report, and does the system use the same definition?
3. Who is the approved recipient in each department and shift, and who is their deputy?
4. How long does the reporter wait before escalating, and by what alternative channel?
5. Who receives results that come back after the patient is discharged or transferred?
6. Where is the clinical decision documented, and how is it linked to the report?
7. Who reviews the periodic reports, and what happens to stalled cases?

If departments give different answers, that is the first gap to close before investing in any new tools.

How does this apply in the Gulf?

The sources cited here are American, and the Joint Commission’s clarifications apply to its own accreditation programmes, not to any Gulf regulation. Each facility should therefore check the requirements of its national regulator and the accreditation body that applies to it, such as the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) or the relevant health authority in the emirate concerned, and link its policy to both in-house and external laboratories.

Clear responsibility matters even more when a visiting doctor orders the test or a sample is referred to an outside laboratory. Agreements should record the point at which the result is handed over and which party accepts follow-up; responsibility does not transfer automatically just because a service contract exists. Do not carry figures or clause numbers from an earlier edition of an accreditation standard into a new policy without checking the edition currently in force.

Conclusion

A critical result has not been reported until a responsible clinician confirms receipt and accepts follow-up. Start by defining what “closed” means and logging each stage, then build an escalation chain tied to the rota, and measure what happens in the cases that stall, not just the average.